Hello, everyone, and how are you today? We hope the weekend was refreshing. It always goes by too fast, yes? In any event, the usual routine is again under way and that means a growing pile of meetings and deadlines and projects. We know you can relate, so please join us for our de rigeur cup of stimulation - Cinnamon Cream Swirl is on the menu this morning. Meanwhile, here are a few items we have plucked from the sky. Hope your day goes well and do stay in touch...
Vertex Cystic Fibrosis Drug Combo Shows Promising Results (The Street)
FDA Lifts Second Hold On Insmed Lung Drug Trial (Reuters)
Pfizer's Lyrica Fails In Diabetes Trial, HIV Study Halted (Bloomberg News)
Pentagon To Limit Antipsychotics For PTSD (Navy Times)
Pharma Generated $33B In M&A In April (Financial Times)
EMA Outlines Manufacturing Docs For Biologics Trials (InPharma Technologist)
Troubled Florida Compounder Linked To Rare Eye Infection (Associated Press)
Covance To Close Arizona Testing Facility (Outsourcing Pharma)
Pfizer Restructures PR; Kerins To Depart (PR Week)
EDITOR'S NOTE: Please check this post for updates
sunrise pic thx to benimoto on flickr